CARE Ratings Ltd

As of June 30, 2026, CARE Ratings Ltd carries a market capitalization of 49.98B, placing it among publicly traded companies globally. Its enterprise value stands at 49.98B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

CARE Ratings Ltd's next confirmed earnings release is scheduled for October 29, 2026.

As of June 30, 2026, CARE Ratings Ltd has 30.06M shares outstanding.

As of June 30, 2026, CARE Ratings Ltd trades at a trailing price-to-earnings ratio of 28.10.

As of June 30, 2026, CARE Ratings Ltd trades at an EV/EBITDA multiple of 24.48 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 10.18 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 26.40 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 49.98B versus a market cap of 49.98B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 7.65M in revenue per employee across its workforce of 642.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, CARE Ratings Ltd recorded 626.95M in income tax expense. That works out to an effective tax rate of 25.81, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 2.43B, leaving 1.78B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 23, 2026, CARE Ratings Ltd's stock has declined approximately 1.75% over the past 52 weeks. The 50-day moving average sits at 1,644.17, while the 200-day moving average is 1,634.37.

Over the twelve months ended June 30, 2026, CARE Ratings Ltd generated 4.91B in revenue and converted that into 1.78B in net income, yielding earnings per share of 59.77. EBITDA reached 2.04B, while operating income came in at 1.89B.

Over the twelve months ended June 30, 2026, CARE Ratings Ltd posted a gross margin of 55.30, reflecting its pricing power and cost economics. The operating margin of 38.57 and net profit margin of 36.19 provide insight into operational efficiency.